By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Verastem, Inc. 

215 First Street
Suite 440
Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-858-0338 Fax: n/a


Company News
Cancer Research UK, MSD And Verastem (VSTM) Collaborate To Trial New Combination Of Immunotherapy Drugs 9/30/2016 9:37:04 AM
Verastem (VSTM) Reports Second Quarter 2016 Financial Results 8/8/2016 11:44:42 AM
Verastem (VSTM) Release: Study Published In Nature Medicine Highlights Potential Role Of FAK Inhibition In Pancreatic Cancer 7/5/2016 11:04:13 AM
Retired Genzyme Chief, Flex Pharma (FLKS) CEO Out as Verastem (VSTM) Shakes up Board 6/15/2016 8:15:17 AM
Verastem (VSTM) To Present At Upcoming Investor Conferences 6/1/2016 4:58:57 PM
Verastem (VSTM) Reports First Quarter 2016 Financial Results 5/10/2016 12:03:37 PM
Verastem (VSTM) Announces The Presentation Of Clinical Data At iMig 2016 5/3/2016 11:30:35 AM
Verastem (VSTM) Names Gregory I. Berk, MD As Chief Medical Officer 4/19/2016 11:39:23 AM
Verastem (VSTM) Co-Founder, Dr. Robert Weinberg, Recognized With Two Prestigious Cancer Research Awards 4/18/2016 11:03:44 AM
Verastem (VSTM) Announces Presentation Of Scientific Data Supporting FAK Inhibition In Combination With Immunotherapy At The Keystone Symposium On Cancer Pathophysiology 3/31/2016 11:30:38 AM